1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. VERASTEM INC
Verastem Inc
XNAS: VSTM

Verastem Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote ca...

Read More
4.89 -0.77 (-13.60%)
56.49% Fall from 52W High
7.1M
XNAS Volume
High volume+loss today

XNAS 08 May, 2026 4:11 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The board meeting for Verastem Inc is scheduled for today, for the purpose of Verastem Inc First Quarter Earnings Results for 2026 See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
8.2 / 100
Momentum Score
Technically Neutral
37.3 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
16
1Yr Price target upside is 235%
8 analysts

8

S

25

W

2

O

1

T

SWOT Analysis

Verastem Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..